Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Mar 2025 for 昱展新藥.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
中華開發生醫創業投資股份有限公司: trading record in brief
All filings by 中華開發生醫創業投資股份有限公司 on record concern 昱展新藥. We count 2 filings; the first trade dates from 25 September 2020 and the latest from 7 March 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 7 March 2025: a transaction, in 昱展新藥. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 中華開發生醫創業投資股份有限公司
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
- 400,000 sharesShareTPExTWMOPS:6785:114/03/07:中華開發生醫創業投資股份有限公司:0yfi64x
- 1,112,000 sharesShareTPExTWMOPS:6785:109/09/25:中華開發生醫創業投資股份有限公司:04yem22
2 of 2 declarations